Julie Belkin, MD
- Assistant Professor, CWRU School of Medicine
Julie K. Belkin, MD, is a native Clevelander who has been with the UH Eye Institute since 1993 and is an assistant professor at Case Western University School of Medicine. She is a board-certified ophthalmologist who completed her BA in Psychology at Northwestern University in 1985 and subsequently completed her medical degree from the Medical College of Ohio in 1989. She performed her ophthalmology residency at Mt. Sinai Medical Center in Cleveland from 1989 – 1993.
Clinical and Research Interests
Dr. Belkin provides comprehensive eye exams and is an expert in cataract and lens implantation surgery. She participated in a National Eye Institute study looking at the effect of cataract surgery on improving dementia in patients with Alzheimer’s disease. She has been involved with the didactic training of our residents for many years.
- 2018 Senior Attending Surgeon-Inaugural Class of Distinguished Physicians University Hospitals Cleveland Medical Center: Awarded to Physicians at University Hospitals for more than 10 years with depth of knowledge in their field, a proven ability to provide compassionate, appropriate, and effective care to all patients, a willingness to acquire and share new knowledge, outstanding interpersonal skills, a commitment to professionalism, and a track record for teaching and inspiring students, residents and fellows
- Cleveland Magazine, Best Doctors 2018
Dr. Belkin enjoys spending time with her family and travelling with her husband. She is a certified SCUBA diver.
- Cataract and Lens Implant Surgery
- Comprehensive Ophthalmology
- Eye Exams
- Eye Implant Surgery
- Ophthalmology - American Board of Ophthalmology
Residency | Ophthalmology
Ophthalmology - Mount Sinai Medical Center Of Cleveland (1990 - 1993)
Internship | Transitional Year
Transitional Year - Mount Sinai Medical Center Of Cleveland (1989 - 1990)
Medical University Of The Ohio College Of Medicine (1989)
Northwestern University (1985)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Julie Belkin did not disclose any Outside Relationships with Industry.